- Research article
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Glucan-rich polysaccharides from Pleurotus sajor-caju (Fr.) Singer prevents glucose intolerance, insulin resistance and inflammation in C57BL/6J mice fed a high-fat diet
© Kanagasabapathy et al.; licensee BioMed Central Ltd. 2012
Received: 11 June 2012
Accepted: 13 December 2012
Published: 21 December 2012
Pleurotus sajor-caju (P. sajor-caju) has been extremely useful in the prevention of diabetes mellitus due to its low fat and high soluble fiber content for thousands of years. Insulin resistance is a key component in the development of diabetes mellitus which is caused by inflammation. In this study, we aimed to investigate the in vivo efficacy of glucan-rich polysaccharide of P. sajor-caju (GE) against diabetes mellitus and inflammation in C57BL/6J mice fed a high-fat diet.
Diabetes was induced in C57BL/6J mice by feeding a high-fat diet. The mice were randomly assigned to 7 groups (n=6 per group). The control groups in this study were ND (for normal diet) and HFD (for high-fat diet). The treated groups were ND240 (for normal diet) (240 mg/kg b.w) and HFD60, HFD120 and HFD240 (for high-fat), where the mice were administrated with three dosages of GE (60, 120, 240 mg GE/kg b.w respectively). Metformin (2 mg/kg b.w) served as positive control. The glucose tolerance test, glucose and insulin levels were measured at the end of 16 weeks. Expressions of genes for inflammatory markers, GLUT-4 and adiponectin in the adipose tissue of the mice were assessed. One-way ANOVA and Duncan’s multiple range tests (DMRT) were used to determine the significant differences between groups.
GE treated groups improved the glucose tolerance, attenuated hyperglycemia and hyperinsulinemia in the mice by up-regulating the adiponectin and GLUT-4 gene expressions. The mice in GE treated groups did not develop insulin resistance. GE also down-regulated the expression of inflammatory markers (IL-6, TNF-α, SAA2, CRP and MCP-1) via attenuation of nuclear transcription factors (NF-κB).
Glucan-rich polysaccharide of P. sajor-caju can serve as a potential agent for prevention of glucose intolerance, insulin resistance and inflammation.
Diabetes is one of the leading non-communicable diseases affecting mankind . It is estimated more than 284 million people are diabetic worldwide and this figure is predicted to double by 2030 . Diabetes mellitus (DM) is a complicated metabolic disorder, characterised by high blood glucose level due to the inability of cells to utilise glucose appropriately. The etiology of type-1 diabetes is the absolute deficiency of insulin secretion, while type 2 diabetes (DM) is a combination of resistance to insulin action and impaired insulin secretion, which accounts for more than 90% of all diabetes cases . Diabetes may lead to microvascular (blindness, renal failure and neuropathy) and macrovascular (stroke and myocardial infarction) complications . It is also considered to be an important risk factor for the development of obesity, hyperinsulinemia, hypertension, dyslipidemia and atherosclerosis .
The current treatment for DM includes insulin and other oral hypoglycemic drugs such as sulphonylurea derivatives, biguanides, thiazolidinediones and alpha glucosidase inhibitors. However, these agents are known to have undesirable side effects such as high blood pressure, dry mouth, constipation, headache, valvular heart disease and obesity . To date, natural products still play an important role as sources of medicine in preventing diabetes thus, the efforts to discover useful drug candidates to combat diabetic complications are going on relentlessly .
Mushrooms are well recognized for their medicinal properties and have been used in traditional medicine for centuries. The medicinal effects of mushrooms include antioxidant, antiviral, antibacterial, antifungal, anti-parasitic, detoxification, immunomodulatory, antitumor, radical scavenging, anti-inflammatory, cardiovascular, anti-hyperlipidemic or anti-hypercholesterolemic, hepatoprotective and anti-diabetic . Edible mushrooms have been used to maintain health and increase longevity since ancient times . In Malaysia, the widely cultivated ‘edible fungal food’ is the genus Pleurotus, commonly referred to as ‘oyster mushrooms’. Oyster mushrooms have been discovered to have definite nutritive and medicinal values and are most popular in countries such as India, China and Japan. Currently, Pleurotus sajor-caju is cultivated throughout the world. It contains good quality proteins and vitamins such as B1, B2, and C and has very little lipid or starch. This mushroom is claimed to be able to reduce the cholesterol level in blood  and prevent hyperlipidemia and this ability is attributed to its low fat and high soluble fiber content .
There are two distinct animal models of obesity; the first type is genetic obesity, as seen in rodent strains such as the Zucker fatty (fa/fa) rat and the leptin-deficient obese (lep ob /lep ob ) mouse, which become obese under various experimental conditions. The second type of mouse model for obesity, C57BL/6J reflects the human condition more closely where the animals develop central adiposity, hyperinsulinemia and hyperglycemia as a result of a combination of genetic and environmental factors such as long term high-fat intake . Hence in this study, the C57BL/6J mouse strain was selected to investigate the potential effects of glucan-rich polysaccharides of P. sajor-caju in mice fed a high fat-diet on metabolic changes pertaining to glucose homeostasis and associated inflammation. The activity was also compared with metformin (a widely used oral anti-diabetic drug).
Fresh fruiting bodies of Pleurotus sajor –caju (10kg) were collected from a mushroom farm in Semenyih (Location - 3°21’19.20”N 101°14’36.35”E), Selangor Darul Ehsan, Malaysia.
Isolation and purification of glucan-rich polysaccharide from hot-aqueous extract of P. sajor-caju (GE)
The isolation and purification of polysaccharide were based on the method described previously . Fruiting bodies of P. sajor-caju was collected and washed with water. It was crushed and boiled in 500 ml of distilled water for 8 hours. The whole mixture was kept overnight at 4°C and then filtered through a linen cloth. The filtrate was centrifuged at 13000 × g for 45 minutes at 4°C. The supernatant was collected and precipitated in ethanol (1:5 [v/v]). It was kept overnight at 4°C and again centrifuged at 13000 × g for 45 minutes. The precipitated material (polysaccharide) was washed with ethanol four times and then freeze-dried. The freeze-dried material was dissolved in 30 ml of distilled water and dialyzed through dialysis tubing made up of cellulose membrane (Sigma-Aldrich, USA) against distilled water for 4 hours. This procedure removed low molecular weight materials. The aqueous solution was then collected from the dialysis bag and freeze-dried to yield crude polysaccharide (GE). The β-glucan level in the extract was estimated using a ß - glucan kit (specific for mushroom and yeast) purchased from Meganzyme International (Ireland).
This study was conducted in conformity with the policies and procedures of the Animal Care and Use Committee of Faculty of Medicine, University of Malaya, with reference to the 8th edition: Guide for the Care and Use of Laboratory Animals by the Institute of Laboratory Animal Research, National Academy of Science, USA. The animal ethics approval was obtained from Animal Care and Use Committee of Faculty of Medicine, University of Malaya (IACUC, UM) (Approval number:ISB/14/07/2010/GK [R]). Female C57BL/6J (ob/ob) mice (7-weeks old) were purchased from BioLasco Laboratory, Taiwan. The animals were kept in stainless steel wire–mesh cages in a room maintained at 21°C and a standard condition of 12-hour light/dark cycle (light period: 8:00–20:00 hour). The animals were allowed free access to food and water, which were provided fresh every day.
Type of diet and concentration of GE administrated to each group
Type of diet
Normal diet only + distilled H2O
Normal diet + 240 mg/kg of body weight GE
High-fat diet only + distilled H2O
High-fat diet + 60 mg/kg of body weight of GE
High-fat diet + 120 mg/kg of body weight of GE
High-fat diet + 240 mg/kg of body weight of GE
High-fat diet + 2 mg/kg of body weight of metformin (anti-diabetic drug)
Oral Glucose Tolerance Test (OGTT)
At the end of 16 weeks, the oral glucose test was carried out on the mice after subjecting to an overnight fast. Blood samples were obtained from a cut in the tail vein of the mice and blood glucose levels were determined using ACCU-CHEK® glucometer and ACCU-CHEK® Advantage test strips. Firstly, the fasting blood glucose levels were measured. Then, GE was administrated to the mice via epi-gastric route using a feeding needle and the blood glucose levels was measured again. Glucose (2 g/kg of body weight) was also administrated to the mice via epi-gastric route. Finally, the blood glucose levels were measured every 30 min for 2 hours (30, 60, 90 and 120 min). According to the protocol of the kit and Lee et al.,  mice with fasting blood glucose level of 7.8 mmol/L (200 mg/dL) and above were considered hyperglycemic meanwhile mice with fasting blood glucose of below 3.9 mmol/L (70 mg/dL) was categorized as hypoglycemic.
Sample collection and analytical methods
At the end of 16 weeks, the mice were anesthetized with ether after withholding food for 12 hours and were sacrificed by aortic exsanguination. Blood samples were collected in SST™ glass serum tubes with gold BD Hemogard™ closure (BD Vacutainer®, USA). Serum samples were separated after centrifugation at 2400 × g for 15 minutes. The samples were stored at −80°C for the estimation of insulin level. Adipose tissues were removed and stored in RNAlater® solution (Applied Biosystems, USA) and refrigerated at 4°C overnight before storing the samples at −80°C for RNA extraction.
Insulin Sensitivity Test
The insulin sensitivity assay was done using Rat Insulin Enzyme Immunoassay kit (SPI-BIO Bertin pharma, France). The assay is based on the competition between unlabeled rat insulin and acethylcholinesterase (AChE) linked to rat insulin (tracer) for limited specific Guinea-Pig anti-rat insulin antiserum sites. The absorbance was read at 410 nm using a microplate reader (Bio-Tek Instruments Inc, USA). Rat insulin of known concentrations (0.08 to 10 ng/ml) was used as a standard for the estimation of insulin concentration and the results were expressed as ng/ml.
Gene expression studies using Real Time – RT-PCR
Gene name and abbreviation
Retinol binding protein 4
Tumor necrosis factor-α
Serum amyloid A 2
Monocyte chemoattractant protein-1
Data are shown as mean ± SD of triplicate assays. One-way analysis of variance was used to determine the significant differences between groups. Statistical significance was accepted at p < 0.05. Duncan’s multiple range tests (DMRT) was used to determine the significant differences between groups. SPSS Statistic software (version 17.0, IBM Corp., USA) was used for all statistical analyses. All figures were drawn using GraphPad Prism 5 (GraphPad Software Inc., California, USA).
Results and discussion
Weight and estimation of β-glucan concentration in GE
GE (12.31g) was obtained from 5500g of fresh P. sajor-caju fruiting bodies. This extract was then used to calculate the content of β-glucan by measuring the concentration of total glucan and α-glucan. The concentration of total glucan in GE was 85.95% (w/w) and the concentrations of α-glucan and β-glucan were 5.4% (w/w) and 80.55% (w/w) respectively. The percentage of β-glucan and α-glucan in dried P. sajor-caju were 1.5% and 0.01% (w/w) respectively. In this study, a detailed analysis of the sugar composition and lingkages was not attempted but Pramanik et al. , reported that the polysaccharides in P.sajor-caju consists of repeating unit of D-glucose, D-galactose, and D-mannose in a molar proportion of 1:1:1 with (1→3),(1→6)-β-glucans and (1→3)-α-glucans linkages.
Effects of GE on glucose tolerance
Effects of GE on blood glucose, serum insulin levels and insulin resistance index
Systemic inflammation has been recognized as a key link between insulin resistance and diabetes . Insulin resistance is characterized by increased expression of pro-inflammatory cytokines, macrophage infiltration into white adipose tissue and an impaired response to insulin in the main insulin target tissues.
Homeostatic model assessment values for insulin resistance (HOMA-IR) were calculated using the formula stated above. The HOMA-IR indices for the HFD group showed an increase of 150% compared to ND group. In spite of feeding a high-fat diet, the insulin resistance indices for HFD60, HFD120 and HFD240 groups were significantly reduced by 44%, 62.4% and 60.8% respectively whilst in HFDMET group, the insulin resistance index was significantly reduced by 56% compared to HFD group. Amelioration of insulin resistance in HFD240 treated group was comparable to the metformin treated group. Thus it is pertinent to suggest that GE was able to prevent hyperglycemia by preventing insulin resistance in the mice fed a high-fat diet.
Reactive oxygen species (ROS) production is one of the many factors that have been suggested to play a role in the development of insulin resistance [19, 20]. Nagata et al.  have demonstrated that up-regulation of genes is responsible for ROS production occurs in both the liver and adipose tissue before the onset of insulin resistance in mice fed a high fat-diet.
Effects of GE on the expression of adipokines and inflammatory markers in adipose tissue
Effects of GE on the expression of adipokines in adipose tissue
After 15 weeks of feeding a high-fat diet, HFD group mice developed hyperglycemia and had reduced glucose tolerance (Figure 1). This could be attributed to the reduced expression of adiponectin. Meanwhile, GE treated groups (HFD120 and HFD240) had increased adiponectin expression and this may explain the better glucose tolerance observed in these groups. Adiponectin is considered to be an anti-diabetic and anti-atherogenic hormone, but conflicting results on its levels in obese and diabetic patients and animal models have been shown in previous studies . Some of them demonstrated declined circulating levels of adiponectin in high-fat diet fed rats  and mice  while others did not observe any changes [27, 28]. A possible explanation for such difference is that the expression of adiponectin, could be altered by multiple factors including both genetic and environmental factors, as well as resting and fasting stages . Meanwhile, GLUT-4 gene, the insulin-responsive glucose transporter, plays a major role in glucose transport. The maintenance of insulin sensitivity in adipose tissue and the development of insulin resistance (IR) is a result of impaired GLUT-4 signalling pathway . In this study, the mice in GE treated groups, showed better glucose tolerance than the mice in HFD group, and the improvement in glucose tolerance was also reflected by the increased GLUT-4 expression in these groups.
On the contrary, RBP-4 has been reported as a factor that is derived from adipose tissue that can cause insulin resistance . The mechanism of RBP-4 activation is still unclear but several reports have shown that increased expression of RBP-4 was found in adipose tissue of mice with adipocyte-specific ablation of GLUT-4 . Increased plasma RBP-4 levels in obese children correlated not only with insulin resistance but also with inflammatory factors . This concurs with the findings in this study that, GE treated groups (HFD60, HFD120 and HFD240) had decreased expression of RPB-4 compared to HFD group. In HFDMET group, the regulation of these adipokines was similar to the GE treated groups.
Effects of GE on the expression of inflammatory markers in adipose tissue
Nuclear factor-κB (NF-κB) controls the regulation of the genes that encode proteins involved in immune and inflammatory responses (i.e., cytokines, chemokines, growth factor immune receptors, cellular ligands, and adhesion molecules) . Diabetes causes reduction in the production of anti-inflammatory adipokines (like adiponectin) and increase in the production of pro-inflammatory cytokines (like IL-6, CRP and SAA-2). This, in turn, leads to the MCP-1 facilitated infiltration of monocytes and macrophages into the adipose tissue . The inflamed state leads to the release of cytokines into adipose tissues that are not normally secreted by the adipose cells. A key cytokine that is released by macrophages but not by differentiated adipocyte, is TNF-α, the key regulator of inflammation which is strongly correlated to the level of insulin resistance in obese and diabetic animal models . Studies have demonstrated that, TNF-α along with IL-6 not only inhibit adiponectin (anti-inflammatory adipokines) expression and impair insulin sensitivity of other tissues but also interfere with adipocyte metabolism at numerous sites including transcriptional regulation, glucose and fatty acid metabolism . The pro-inflammatory cytokine IL-6 was among the first to be implicated as a predictor of insulin resistance. Finally, these pro-inflammatory cytokines (IL-6 and TNF-α) mediate distant inflammatory effects, including activation of CRP and SAA-2 . The SAA proteins are derived from distinct genes; human express SAA-1, SAA-2, SAA-3 and SAA-4. In this study, only SAA-2 protein was studied because SAA-2 expression increases dramatically during acute inflammatory responses and adipocytes have been suggested to be a major contributor of SAA-2 . Meanwhile, CRP is an acute phase reactant. Circulating concentrations of SAA-2 and CRP are also increased in individuals with impaired glucose tolerance and are considered to be a marker for insulin resistance .
The HFD group had higher expression of the pro-inflammatory markers compared to the GE treated groups and metformin treated group. ROS and endoplasmic reticulum (ER) stress have been reported to be increased by adiposity and consumption of high-fat diet may activate NF-κB signalling cascade in the adipose tissue . When NF-κB signaling cascade is activated, increased MCP-1 results in a dramatic elevation of macrophage infiltration, promoting the downstream secretion of pro-inflammatory markers namely, TNF-α and IL-6 and finally this increases the expression of CRP and SAA-2. The expression of these pro-inflammatory markers in HFD, are known to initiate and amplify insulin resistance in the adipose tissue as observed in this study. However, the NF-κB activity in GE and metformin treated groups, was significantly down-regulated compared to the HFD group. Thus, the expression of TNF-α and IL-6 also decreased in these groups. Similarly, the expressions of SAA-2 and CRP were also down-regulated in GE and metformin treated groups compared to HFD group. Besides that, the local enhancement in adiponectin expression induced by GE might also be partly responsible for the reduced inflammatory-cytokine expression levels in these groups . Similar findings have been reported on adipose tissue treated with various natural substances such as grape seed procyanidins  and tocotrienol .
Polysaccharide of P. sajor-caju which is rich in β-glucans (GE) (240mg/kg of body weight) prevented the occurrence of glucose intolerance, hyperglycemia and hyperinsulinemia/insulin resistance in C57BL/6J mice fed a high-fat diet by up-regulating the expression of GLUT-4 and adiponectin genes and down-regulating the expression of NF-κB. The properties displayed by GE were comparable to metformin (positive control). GE could serve as a potential candidate for prevention of glucose intolerance, insulin resistance and inflammation.
The authors are grateful to the University of Malaya and Ministry of Higher Education, Malaysia (MOHE) for providing grants PS423/2010A, RG083-09AFR and HIR F000002-21001.
- Simpson RW, Shaw JE, Zimmet PZ: The prevention of type 2 diabetes – lifestyle change or pharmacotherapy? A challenge for 21st century. Diabetes Res Clinical Prac. 2003, 59: 165-180. 10.1016/S0168-8227(02)00275-9.View ArticleGoogle Scholar
- Hamza N, Berke B, Cheze C, Agli AN, Robinson P, Gin H: Prevention of type 2 diabetes induced by high fat diet in the C57BL/6j mouse by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. J Ethnopharmacol. 2010, 128: 513-518. 10.1016/j.jep.2010.01.004.View ArticlePubMedGoogle Scholar
- Umar AR, Ahmed QU, Muhammad BY, Dogarai BBS, Mat-Soad SZ: Anti-hyperglycemic activity of the leaves of Tetracera scandens Linn. Merr. in allaxon induced diabetic rats. J Ethnopharmacol. 2010, 131: 140-145. 10.1016/j.jep.2010.06.016.View ArticlePubMedGoogle Scholar
- Yumuk VD, Hatemi H, Tarakchi T, Uyar N, Turan N, Bagriacik N: High prevalence of obesity and diabetes mellitus in Konya, a central Anatolian city in Turkey. Diabetes Res Clinical Prac. 2005, 70: 151-158. 10.1016/j.diabres.2005.03.030.View ArticleGoogle Scholar
- Bailey CJ: Insulin resistance and antidiabetic drugs. Biochem Pharmacol. 1999, 58: 1511-1520. 10.1016/S0006-2952(99)00191-4.View ArticlePubMedGoogle Scholar
- Slovacek L, Pavlik V, Slovackova B: The effect of sibutramine therapy on occurance of depression symptoms among obese patients. Nutr Metab Cardiovascular Disease. 2008, 18: 43-44.View ArticleGoogle Scholar
- Jie J, Zhang X, Hu YS, Wu Y, Wang QZ, Li NN: Evaluation of in vivo antioxidant activities of Ganoderma lucidum polysaccharides in STZ-diabetic rats. Food Chem. 2009, 115: 32-36. 10.1016/j.foodchem.2008.11.043.View ArticleGoogle Scholar
- Wasser SP: Current findings, future trends, and unsolved problems in studies of medicinal mushrooms. App Microbiol Biotechnol. 2011, 89: 1323-1332. 10.1007/s00253-010-3067-4.View ArticleGoogle Scholar
- Cimerman NG: Medicinal value of the genus Pleurotus (Fr.) P.Karst. (Agaricales s.i., Basidiomycetes). Int J Med Mushrooms. 1999, 1: 69-80.View ArticleGoogle Scholar
- Pramanik M, Mondal S, Chakraborthy I, Rout D, Islam SS: Structural analysis of a water-soluable glucan (Fr I) of an edible mushroom, Pleurotus sajor-caju. Carbohydrate Res. 2007, 342: 2670-2675. 10.1016/j.carres.2007.08.012.View ArticleGoogle Scholar
- Schneider I, Kressel G, Meyer A, Krings U, Berger RG, Hahn A: Lipid lowering effects of oyster mushroom (Pleurotus ostreatus) in humans. J Functional Foods. 2011, 3: 17-24. 10.1016/j.jff.2010.11.004.View ArticleGoogle Scholar
- Moon HS, Lee HG, Seo GH, Chung CH, Kim TG, Choi YJ: Antiobesity effect of PEGylated conjugated linoleic acid on high fat diet induced obese mice C57BL/6J (ob/ob) mice: attenuation of insulin resistance and enhancement of antioxidant defenses. J Nutr Biochem. 2009, 20: 187-194. 10.1016/j.jnutbio.2008.02.001.View ArticlePubMedGoogle Scholar
- Roy SK, Maiti D, Mondal S, Das D, Islam SS: Structural analysis of a polysaccharide isolated from the aqueous extract of an edible mushroom, Pleurotus sajor-caju, cultivar Black Japan. Carbohydrate Res. 2008, 343: 1108-1113. 10.1016/j.carres.2008.02.015.View ArticleGoogle Scholar
- Lee HS, Park HJ, Chun HK, Cho SY, Cho SM, Lillehoj HS: Dietary phytic acids lowers the blood glucose level in diabetic KK mice. Nutr Res. 2006, 26: 474-479. 10.1016/j.nutres.2006.06.017.View ArticleGoogle Scholar
- Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turmer RC: Homeostasis model assessment: insulin resistant and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.View ArticleGoogle Scholar
- Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2 –ΔΔCt method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.View ArticlePubMedGoogle Scholar
- Pramanik M, Mondal S, Chakraborthy I, Rout D, Islam SS: Structural investigation of polysaccharides (Fr II) isolated from aqueous extract of an edible mushroom, Pleurotus sajor-caju. Carbohydr Res. 2005, 340: 629-636. 10.1016/j.carres.2004.12.032.View ArticlePubMedGoogle Scholar
- Scheja L, Heese B, Seedorf K: Beneficial effects of IKK –deficiency on body weight and insulin sensitivity are lost in high fat diet-induced obesity in mice. Biochem Biophysical Res Comm. 2011, 407: 288-294. 10.1016/j.bbrc.2011.02.137.View ArticleGoogle Scholar
- Roberts CK, Sindhu KK: Oxidative stress and metabolic syndrome. Life Sci. 2009, 84: 705-712. 10.1016/j.lfs.2009.02.026.View ArticlePubMedGoogle Scholar
- Nagata M, Ijichi S, Hashiguchi T, Morioka H, Arimura K: Metabolic syndrome-related markers in obese university students in Kagoshima, Japan: Implications of uric acid and plasminogen activator inhibitor type-1. Diabetes Metab Syndrome: Clinical Res Rev. 2009, 3: 96-102. 10.1016/j.dsx.2009.02.009.View ArticleGoogle Scholar
- Ando K, Fujita T: Metabolic syndrome and oxidative stress. Free Radical Biol Med. 2009, 47: 213-218. 10.1016/j.freeradbiomed.2009.04.030.View ArticleGoogle Scholar
- Zou C, Shao J: Role of adipocytokines in obesity-associated insulin resistance. J Nutr Biochem. 2008, 19: 277-286. 10.1016/j.jnutbio.2007.06.006.View ArticlePubMedGoogle Scholar
- Shoelson SE, Laura H, Naaz A: Obesity, inflammation and insulin resistance. Gastroenterol. 2007, 132: 2169-2180. 10.1053/j.gastro.2007.03.059.View ArticleGoogle Scholar
- Bonnard C, Durand A, Vidal H, Rieusset J: Changes in adiponectin, its receptor and AMPK activity in tissues of diet induced-diabetic mice. Diabetes Metab. 2008, 34: 52-61. 10.1016/j.diabet.2007.09.006.View ArticlePubMedGoogle Scholar
- Lee L, Alloosh M, Saxena R, Van-Alstine W, Watkins BA, Klaunig JE: Nutritional model of steatohepatitis and metabolic syndrome in the ossabaw miniature swine. Hepatol. 2009, 50: 56-67. 10.1002/hep.22904.View ArticleGoogle Scholar
- Peng Y, Rideout D, Rakita S, Sajan M, Farese R, You M: Downregulation of adiponectin/adipor2 is associated with steatohepatitis in obese mice. J Gastrointestinal Surgery. 2009, 13: 2043-2049. 10.1007/s11605-009-1032-2.View ArticleGoogle Scholar
- Yang RZ, Lee MJ, Hu H, Pollin TI, Ryan AS, Nicklas BJ: Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med. 2006, 3: e287-10.1371/journal.pmed.0030287.View ArticlePubMedPubMed CentralGoogle Scholar
- Townsend KL, Lorenzi MM, Widmaier EP: High-fat diet-induced changes in body mass and hypothalamic gene expression in wild-type and leptin-deficient mice. Endocrine. 2008, 33: 176-188. 10.1007/s12020-008-9070-1.View ArticlePubMedGoogle Scholar
- Zhang W, Liu CQ, Wang PW, Sun SY, Su WJ, Zhang HJ: Puerarin improves insulin resistance and modulates adipokine expression in rats fed a high-fat diet. Eur J Pharmacol. 2010, 649: 398-402. 10.1016/j.ejphar.2010.09.054.View ArticlePubMedGoogle Scholar
- Miura S, Tsunoda N, Ikeda S, Kai Y, Ono M, Maruyama K: Regulatory sequence elements of mouse GLUT4 gene expression in adipose tissue. Biochem Biophys Res Comm. 2003, 312: 277-284. 10.1016/j.bbrc.2003.10.114.View ArticlePubMedGoogle Scholar
- Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR: Retinol-binding protein 4 and insulin resistance in lean, obese and diabetic subjects. Eng J Med. 2006, 354: 2552-2563. 10.1056/NEJMoa054862.View ArticleGoogle Scholar
- Wang C, Mao X, Wang L, Liu M, Wetzel MD, Guan KL: Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1. J Biol Chem. 2007, 282: 1991-1996.Google Scholar
- Balagopal P, Graham TE, Kahn BB, Altomare A, Funanage V, George D: Reduction of elevated serum retinol-binding protein 4 in obese children lifestyle intervention: association with sub-clinical inflammation. J Clinical Endocrinol Metab. 2007, 7: 2006-2012.Google Scholar
- Ferrante AW: Obesity induced inflammation: a metabolic dialogue in the language of inflammation. J Int Med. 2007, 262: 408-414. 10.1111/j.1365-2796.2007.01852.x.View ArticleGoogle Scholar
- Dandona P, Aljada A, Bandyopadhyay A: Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004, 25: 4-7. 10.1016/j.it.2003.10.013.View ArticlePubMedGoogle Scholar
- Mohanty P, Aljada A, Ghanim H, Hofmeyer D, Tripathy D, Syed T: Evidence for a potent anti-inflammatory effect of rosiglitazone. J Clinical Endocrinol Metab. 2004, 89: 2728-2735. 10.1210/jc.2003-032103.View ArticleGoogle Scholar
- Kuhad A, Chopra K: Attenuation of diabetic nephropathy by tocotrienol; involvement of NFKB signaling pathway. Life Sci. 2009, 84: 296-301. 10.1016/j.lfs.2008.12.014.View ArticlePubMedGoogle Scholar
- Terra X, Pallares V, Ardevol A, Blade C, Larrea JF, Pujadas G: Modulatory effect of grape seed procyanidins on local systemic inflammation in diet induced obesity rats. J Nutr Biochem. 2011, 22: 380-387. 10.1016/j.jnutbio.2010.03.006.View ArticlePubMedGoogle Scholar
- Kern PA, Di G, Gregoria B, Lu T, Rassouli N, Ranganathan G: Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance and TNF-α expression. Diabetes. 2001, 52: 1779-1785.View ArticleGoogle Scholar
- Kim SO, Yun SJ, Jung B, Lee EH, Hahm DH, Shim I: Hypolipidemic effects of crude extract of adlay seed in obesity rat fed high fat diet: relations of TNF-α and leptin mRNA expressions and serum lipid levels. Life Sci. 2004, 75: 1391-1404. 10.1016/j.lfs.2004.03.006.View ArticlePubMedGoogle Scholar
- Koh KK, Han SH, Quon MJ: Inflammatory markers and the metabolic syndrome; insight from therapeutic interventions. J Am Coll Cardiol. 2005, 46: 1978-1985. 10.1016/j.jacc.2005.06.082.View ArticlePubMedGoogle Scholar
- Pannacciulli N, Cantatore FP, Minenna A, Bellacicco M, Giorgino R, De-Pergola G: C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. Int J Obesity Related Metab Disorder. 2001, 25: 1416-1420. 10.1038/sj.ijo.0801719.View ArticleGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/12/261/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.